Xtx Topco LTD Anavex Life Sciences Corp. Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $62,903 - $78,014	8,212 Added 62.16%	21,423 $174,000
Q1 2023 May 12, 2023	SELL	$8.32 - $11.75 $208,632 - $294,643	-25,076 Reduced 65.49%	13,211 $113,000
Q4 2022 Feb 14, 2023	BUY	$7.65 - $14.43 $292,895 - $552,481	38,287 New	38,287 $354,000

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.